18th Jun 2014 09:31
LONDON (Alliance News) - Deltex Medical Group PLC said Wednesday that doctors in the US using its oesophageal Doppler monitoring equipment will receive increased levels of reimbursement.
The company's technology is used to measure blood flow during surgery by generating a low-frequency ultrasound signal utilising the Doppler effect. The Doppler effect, discovered by Austrian physicist Christian Doppler, is the change in frequency of a wave for an observer moving relative to its source, such as the way in which the noise of a siren changes when it passes by.
US Centres for Medicare and Medicaid Services will now pay an average of USD111.77 for the use of the technology, up 10% from the previous standard level of USD101 in 2013.
"This increase in reimbursement level is timely. More doctors in the USA are showing an interest in intra-operative fluid management," said Chief Executive Ewan Phillips in a statement.
Shares in Deltex Medical were trading down 0.7% at 10.55 pence Wednesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical